Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
May facilitate clinician recall of evidence-based therapies; leaves open prospective validation of implementation gains.
Implementation of the numerous lifestyle and medical management options for secondary prevention of cardiovascular disease remains a daunting goal for primary care physicians and cardiologists alike. Despite the existence of expert consensus guidelines on cardiovascular prevention by the American College of Cardiology and the American Heart Association, therapies known to improve patient care and decrease morbidity and mortality remain underutilized. This review attempts to simplify cardiovascular risk reduction by summarizing key clinical trials in an "ABC" format. We believe that if health care providers and patients use such a format, important lifestyle and pharmacologic options will more likely be addressed.
No takes yet. Share an insight, caveat, or question.
Gluckman et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: